Taken together, the data indicate that knockdown of S100A6 can aggravate AKI in mice following both I/R and cisplatin treatments by activating the PKC‐η/ROS/p38MAPK and JNK axes. The gene discussed is MAPK8; the disease is acute kidney injury.